You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Ethical Considerations in REM Sleep Behavior Disorder

Vertrees, Stephanie MD; Greenough, Glen P. MD, FAASM

CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000427223.22963.d4
Ethical Perspectives
Abstract

ABSTRACT: A patient diagnosed with REM behavior sleep disorder (RBD) has as much as a 65% risk of developing an α-synucleinopathy. Currently, it is not possible to predict whether an individual will develop a disease, or, if so, which disease.The neurologist treating the patient must consider (1) the difference between disclosing a diagnosis and disclosing the risk of a diagnosis; (2) whether to disclose this risk to patients; and (3) if deciding to disclose the risk, the appropriate timing of such a conversation.

Author Information

Address correspondence to Dr Stephanie Vertrees, Austin Neurology and Sleep Associates, 711-E1 West 38th St, Austin, TX 78705, svertrees@austinneurosleep.com.

Relationship Disclosure: Dr Vertrees reports no disclosure. Dr Greenough has received a grant from Dartmouth Center for Clinical and Translational Science Pilot and Collaborative Studies Program.

Unlabeled Use of Products/Investigational Use Disclosure: Drs Vertrees and Greenough report no disclosures.

© 2013 American Academy of Neurology